المؤلفون: Lafayette R; Stanford Glomerular Disease Center, Stanford University Medical Center, Stanford, California, USA.

المصدر: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Sep; Vol. 29 Suppl 2, pp. 44-46.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE

مواضيع طبية MeSH: Glomerulonephritis, IGA*/immunology , Glomerulonephritis, IGA*/drug therapy , Complement Inactivating Agents*/therapeutic use , Complement Inactivating Agents*/pharmacology , Complement Activation*/drug effects, Humans ; Complement System Proteins/immunology ; Complement System Proteins/metabolism ; Animals ; Complement Pathway, Alternative/drug effects ; Complement Pathway, Alternative/immunology

المصدر: Retina (Philadelphia, Pa.) [Retina] 2024 Sep 01; Vol. 44 (9S), pp. S1-S8.

نوع المنشور: Editorial; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Complement Inactivating Agents*/therapeutic use , Complement Inactivating Agents*/adverse effects , Geographic Atrophy*/drug therapy , Geographic Atrophy*/diagnosis, Humans

المؤلفون: Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., He G; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Tong H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Lin Z; Department of Hematology, Affiliated Hospital of Nantong University, Jiangsu, China., Wang X; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China., Chai-Adisaksopha C; Faculty of Medicine Chiang Mai University, Chiang Mai, Thailand., Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Brodsky A; Hematology Division, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina., Hantaweepant C; Faculty of Medicine Siriraj Hospital, Division of Hematology, Department of Medicine, Mahidol University, Bangkok, Thailand., Dumagay TE; Division of Hematology, Department of Medicine, University of the Philippines, Philippine General Hospital, Manila, Philippines., Demichelis-Gómez R; Department of Hematology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Rojnuckarin P; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Sun J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Höglund M; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Jang JH; Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Gaya A; Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Silva F; Hematology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal., Obara N; Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan., Kelly RJ; Division of Haematology and Immunology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Beveridge L; Genentech, Inc., South San Francisco, California, USA., Buatois S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chebon S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gentile B; Genentech, Inc., South San Francisco, California, USA., Lundberg P; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sreckovic S; Genentech, Inc., South San Francisco, California, USA., Nishimura JI; Osaka University Graduate School of Medicine, Osaka, Japan., Risitano A; Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy., Han B; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking, China.

المصدر: American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1768-1777. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hemoglobinuria, Paroxysmal*/drug therapy , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Complement Inactivating Agents*/therapeutic use , Complement Inactivating Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Adult ; Hemolysis/drug effects ; Complement C5/antagonists & inhibitors ; Aged

المؤلفون: Scheinberg P; Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil., Clé DV; Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil., Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea., Nur E; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Yenerel MN; Division of Hematology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey., Barcellini W; Hematology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Bonito D; CEPHO/Faculty of Medicine of ABC, São Paulo, Brazil., Giai V; Department of Hematology and Oncology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Hus M; Department of Hemato Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland., Lee Y; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea., Lekue CB; Department of Hematology, Hospital Universitario de Basurto, Bilbao, Spain., Panse J; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Centre for Integrated Oncology (CIO), Cologne, Germany., Ueda Y; Department of Hematology and Oncology, Graduate School of Medicine, Faculty of Medicine, Osaka University, Suita, Japan., Buatois S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gentile B; Genentech, Inc., South San Francisco, California, USA., Kiialainen A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Patel H; Genentech, Inc., South San Francisco, California, USA., Sreckovic S; Genentech, Inc., South San Francisco, California, USA., Uguen M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Edwards J; Indiana Blood and Marrow Transplantation, Indianapolis, Indiana, USA., Nagy Z; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary., Kulasekararaj AG; Department of Haematological Medicine, King's College Hospital, London, UK.; National Institute for Health Research and Wellcome King's Clinical Research Facility and King's College London, London, UK.

المصدر: American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1757-1767. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hemoglobinuria, Paroxysmal*/drug therapy , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Complement Inactivating Agents*/therapeutic use , Complement Inactivating Agents*/adverse effects , Complement Inactivating Agents*/administration & dosage, Humans ; Female ; Male ; Middle Aged ; Adult ; Aged ; Complement C5/antagonists & inhibitors ; Treatment Outcome

المؤلفون: Habib AA; University of California, Irvine, CA, USA., Klink AJ; Cardinal Health, Dublin, OH, USA., Muppidi S; Stanford Neuroscience Health Center, Palo Alto, CA, USA., Parthan A; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.; FibroGen Inc., San Francisco, CA, USA., Sader SC; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Balanean A; Cardinal Health, Dublin, OH, USA., Gajra A; Cardinal Health, Dublin, OH, USA.; Hematology-Oncology Associates of CNY, East Syracuse, NY, USA., Nowak RJ; Yale University School of Medicine, New Haven, CT, USA., Howard JF Jr; Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA. howardj@neurology.unc.edu.

مؤلفون مشاركون: ELEVATE Study Group

المصدر: Journal of neurology [J Neurol] 2024 Sep; Vol. 271 (9), pp. 6114-6126. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Myasthenia Gravis*/drug therapy , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Complement Inactivating Agents*/administration & dosage , Complement Inactivating Agents*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; United States ; Activities of Daily Living

المؤلفون: Brandsema JF; Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Ginsberg M; Department of Neurology, Akron Children's Hospital, Akron, Ohio., Hoshino H; Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan., Mimaki M; Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan., Nagata S; Department of Pediatrics, Tokyo Women's Medical University School of Medicine, Tokyo, Japan., Rao VK; Division of Neurology, Lurie Children's Hospital, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Ruzhansky K; Department of Neurology, Medical University of South Carolina, Charleston, South Carolina., Suresh N; Department of Neurology, University of South Florida, Tampa, Florida., Tiongson E; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, California., Yamanouchi H; Department of Pediatrics, Comprehensive Epilepsy Center, Saitama Medical University, Saitama, Japan., Frick G; Alexion, AstraZeneca Rare Disease, Boston, Massachusetts. Electronic address: Glen.Frick@alexion.com., Hicks E; Alexion, AstraZeneca Rare Disease, Boston, Massachusetts., Liao S; Alexion, AstraZeneca Rare Disease, Boston, Massachusetts., Howard JF Jr; Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina.

مؤلفون مشاركون: MG 303 Study Group

المصدر: Pediatric neurology [Pediatr Neurol] 2024 Jul; Vol. 156, pp. 198-207. Date of Electronic Publication: 2024 Apr 26.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 8508183 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5150 (Electronic) Linking ISSN: 08878994 NLM ISO Abbreviation: Pediatr Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/pharmacology , Myasthenia Gravis*/drug therapy , Complement Inactivating Agents*/administration & dosage , Complement Inactivating Agents*/pharmacology, Humans ; Adolescent ; Male ; Female ; Child ; Treatment Outcome ; Quality of Life ; Outcome Assessment, Health Care

المؤلفون: Trujillo H; Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Huerta A; Nephrology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Alonso R; Pneumology Department, Lung Transplant Unit, Hospital Universitario 12 de Octubre, Madrid, Spain., Serrano ML; Nephrology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Aguilar M; Pneumology Department, Lung Transplant Unit, Hospital Universitario Puerta de Hierro, Madrid, Spain., Morales E; Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Cavero T; Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.

المصدر: Clinical transplantation [Clin Transplant] 2024 Sep; Vol. 38 (9), pp. e15443.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print Cited Medium: Internet ISSN: 1399-0012 (Electronic) Linking ISSN: 09020063 NLM ISO Abbreviation: Clin Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Thrombotic Microangiopathies*/etiology , Thrombotic Microangiopathies*/drug therapy , Lung Transplantation*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Salvage Therapy* , Complement Inactivating Agents*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Follow-Up Studies ; Prognosis ; Adult ; Aged ; Postoperative Complications/drug therapy ; Postoperative Complications/etiology ; Retrospective Studies ; Risk Factors ; Graft Rejection/etiology ; Graft Rejection/drug therapy ; Kidney Function Tests ; Graft Survival/drug effects

المؤلفون: Steggerda JA; Division of Abdominal Transplant Surgery, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA., Heeger PS; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.; Division of Nephrology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

المصدر: Transplantation [Transplantation] 2024 Sep 01; Vol. 108 (9), pp. 1882-1894. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6080 (Electronic) Linking ISSN: 00411337 NLM ISO Abbreviation: Transplantation Subsets: MEDLINE

مواضيع طبية MeSH: Complement System Proteins*/immunology , Organ Transplantation*/adverse effects , Graft Survival*/drug effects , Graft Survival*/immunology , Graft Rejection*/immunology , Graft Rejection*/prevention & control , Complement Inactivating Agents*/therapeutic use, Humans ; Animals ; Complement Activation/drug effects ; Treatment Outcome

المؤلفون: Hillmen P; Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA., Horneff R; Swedish Orphan Biovitrum AB, 171 65 Stockholm, Sweden., Yeh M; Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA., Kolev M; Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA., Deschatelets P; Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 31; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Hemoglobinuria, Paroxysmal*/drug therapy , Hemoglobinuria, Paroxysmal*/metabolism , Complement Inactivating Agents*/therapeutic use, Humans ; CD59 Antigens/metabolism ; CD59 Antigens/genetics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/pharmacology ; Complement Activation/drug effects ; CD55 Antigens/metabolism ; CD55 Antigens/genetics

المؤلفون: Lai E; Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, USA., Lee T; Ophthalmology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA., Lee C; Elman Retina Group, Baltimore, Maryland, USA., Schechet SA; Elman Retina Group, Baltimore, Maryland, USA schechets@gmail.com.

المصدر: BMJ open ophthalmology [BMJ Open Ophthalmol] 2024 Aug 29; Vol. 9 (1). Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Editorial

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101714806 Publication Model: Electronic Cited Medium: Internet ISSN: 2397-3269 (Electronic) Linking ISSN: 23973269 NLM ISO Abbreviation: BMJ Open Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Inactivating Agents*/therapeutic use , Geographic Atrophy*/drug therapy, Humans